• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类恒定链Vα24 + 自然杀伤T细胞通过与白细胞介素-10处理的树突状细胞相互作用获得调节功能。

Human invariant Valpha24+ natural killer T cells acquire regulatory functions by interacting with IL-10-treated dendritic cells.

作者信息

Yamaura Ayako, Hotta Chie, Nakazawa Masatoshi, Van Kaer Luc, Minami Mutsuhiko

机构信息

Department of Immunology, Graduate School of Medicine, Yokohama City University, 3-9 Fuku-ura, Kanazawa-ku, Yokohama, Japan.

出版信息

Blood. 2008 Apr 15;111(8):4254-63. doi: 10.1182/blood-2007-04-085142. Epub 2008 Feb 12.

DOI:10.1182/blood-2007-04-085142
PMID:18270329
Abstract

Glycolipid-reactive Valpha24(+) invariant natural killer T (iNKT) cells have been implicated in regulating a variety of immune responses and in the induction of immunologic tolerance. Activation of iNKT cells requires interaction with professional antigen-presenting cells, such as dendritic cells (DCs). We have investigated the capacity of distinct DC subsets to modulate iNKT cell functions. We demonstrate that tolerogenic DCs (tolDCs), generated by treatment of monocyte-derived DC with interleukin (IL)-10, induced regulatory functions in human iNKT cells. tolDCs, compared with immunogenic DCs, had reduced capacity to induce iNKT-cell proliferation, but these cells produced large amounts of IL-10 and acquired an anergic phenotype. These anergic Valpha24(+) iNKT cells were able to potently inhibit allogeneic CD4(+) T-cell proliferation in vitro. Furthermore, the anergic Valpha24(+) iNKT cells could suppress DC maturation in vitro. We conclude that the interaction of iNKT cells with tolDCs plays an important role in the immune regulatory network, which might be exploited for therapeutic purposes.

摘要

糖脂反应性Vα24(+)不变自然杀伤T细胞(iNKT细胞)参与调节多种免疫反应并诱导免疫耐受。iNKT细胞的激活需要与专职抗原呈递细胞相互作用,如树突状细胞(DCs)。我们研究了不同DC亚群调节iNKT细胞功能的能力。我们证明,用白细胞介素(IL)-10处理单核细胞来源的DC所产生的耐受性DC(tolDCs)可诱导人iNKT细胞的调节功能。与免疫原性DC相比,tolDCs诱导iNKT细胞增殖的能力降低,但这些细胞产生大量IL-10并获得无反应表型。这些无反应的Vα24(+) iNKT细胞能够在体外有效抑制同种异体CD4(+) T细胞增殖。此外,无反应的Vα24(+) iNKT细胞可在体外抑制DC成熟。我们得出结论,iNKT细胞与tolDCs的相互作用在免疫调节网络中起重要作用,这可能被用于治疗目的。

相似文献

1
Human invariant Valpha24+ natural killer T cells acquire regulatory functions by interacting with IL-10-treated dendritic cells.人类恒定链Vα24 + 自然杀伤T细胞通过与白细胞介素-10处理的树突状细胞相互作用获得调节功能。
Blood. 2008 Apr 15;111(8):4254-63. doi: 10.1182/blood-2007-04-085142. Epub 2008 Feb 12.
2
Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation.无能性恒定自然杀伤T细胞对非炎性树突状细胞的配体依赖性诱导可将自身免疫性炎症降至最低。
J Immunol. 2008 Aug 15;181(4):2438-45. doi: 10.4049/jimmunol.181.4.2438.
3
Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.通过CD11c⁻T细胞实现树突状细胞成熟以及通过α-半乳糖神经酰胺实现Vα24⁺自然杀伤T细胞激活。
Int J Cancer. 2005 Nov 1;117(2):265-73. doi: 10.1002/ijc.21197.
4
Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells.干扰素-α 可消除人源耐受性树突状细胞诱导的免疫耐受。
PLoS One. 2011;6(7):e22763. doi: 10.1371/journal.pone.0022763. Epub 2011 Jul 27.
5
Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.树突状细胞是人类恒定链α24 +自然杀伤T细胞细胞毒性活性的靶标:一种重要的免疫调节功能。
Exp Hematol. 2000 Mar;28(3):276-82. doi: 10.1016/s0301-472x(99)00149-6.
6
Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.(树突状细胞刺激的)恒定自然杀伤T细胞、自然杀伤细胞和细胞因子诱导的杀伤细胞的频率、组成和/或抗白血病活性对急性髓系白血病、急性淋巴细胞白血病和慢性淋巴细胞白血病患者预后的意义。
J Immunother. 2017 Jul/Aug;40(6):224-248. doi: 10.1097/CJI.0000000000000171.
7
Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.顺铂通过大量产生白细胞介素-10对Toll样受体激动剂作出反应,诱导产生耐受性树突状细胞,从而促进偏向于辅助性T细胞2型和1型调节性T细胞的免疫反应。
Oncotarget. 2016 Jun 7;7(23):33765-82. doi: 10.18632/oncotarget.9260.
8
Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.健康老年人中恒定链α24β11自然杀伤T(iNKT)细胞的频率和增殖反应降低。
Biogerontology. 2006 Oct-Dec;7(5-6):483-92. doi: 10.1007/s10522-006-9063-5.
9
Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells.长期培养的恒河猴脾脏来源的自然杀伤T细胞的表型和功能特性
J Immunol. 2003 Sep 15;171(6):2904-11. doi: 10.4049/jimmunol.171.6.2904.
10
Induction of tolerance by IL-10-treated dendritic cells.白细胞介素-10处理的树突状细胞诱导免疫耐受
J Immunol. 1997 Nov 15;159(10):4772-80.

引用本文的文献

1
Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.iNKT 细胞受 HLA-G-ILT2 检查点抑制和 HLA-G 表达的耐受 DC 的不良刺激。
Front Immunol. 2021 Jan 11;11:608614. doi: 10.3389/fimmu.2020.608614. eCollection 2020.
2
Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.人胚干细胞来源的树突状细胞经 CD1d 稳定修饰后能有效地刺激抗肿瘤的不变自然杀伤 T 细胞反应。
Stem Cells Transl Med. 2014 Jan;3(1):69-80. doi: 10.5966/sctm.2013-0070. Epub 2013 Nov 29.
3
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected].
长链脂肪酸硫苷脂刺激的 NKT 细胞可显著降低非肥胖型糖尿病小鼠 1 型糖尿病的发生率[更正]。
PLoS One. 2012;7(5):e37771. doi: 10.1371/journal.pone.0037771. Epub 2012 May 23.
4
How tolerogenic dendritic cells induce regulatory T cells.如何诱导耐受性树突状细胞产生调节性 T 细胞。
Adv Immunol. 2010;108:111-65. doi: 10.1016/B978-0-12-380995-7.00004-5.
5
Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.在与人类嗜T淋巴细胞病毒1型(HTLV-1)相关疾病患者中,具有抗HTLV-1活性的恒定自然杀伤T细胞严重缺失。
Blood. 2009 Oct 8;114(15):3208-15. doi: 10.1182/blood-2009-02-203042. Epub 2009 Aug 7.